{"id":12755,"date":"2022-12-28T14:27:19","date_gmt":"2022-12-28T14:27:19","guid":{"rendered":"https:\/\/dev.haugpartners.com\/?post_type=article&p=12755"},"modified":"2024-09-26T09:05:42","modified_gmt":"2024-09-26T09:05:42","slug":"haug-partners-successfully-defends-takedas-vyvanse-patents-at-trial-against-generic-challenge","status":"publish","type":"article","link":"https:\/\/haugpartners.com\/article\/haug-partners-successfully-defends-takedas-vyvanse-patents-at-trial-against-generic-challenge\/","title":{"rendered":"Haug Partners Successfully Defends Takeda\u2019s Vyvanse\u00ae Patents At Trial Against Generic Challenge"},"featured_media":12759,"template":"","categories":[102],"acf":[],"_links":{"self":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article\/12755"}],"collection":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/types\/article"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media\/12759"}],"wp:attachment":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media?parent=12755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/categories?post=12755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}